Lilian Lee

Senior Director Of Clinical Science at Freenome

Lilian Lee, Ph.D. has a diverse work experience in the field of clinical research and pharmaceutical sciences. Lilian is currently serving as the Director of Clinical Science at Freenome since August 2021. Prior to that, they worked at Medtronic as the Clinical Strategy, Core Team Leader from July 2020 to September 2021.

From 2018 to 2020, Lilian was the Onyx ONE Clear Clinical Trial Lead at Medtronic Vascular. Lilian successfully managed the planning and execution of the trial, exceeding milestones and goals. Lilian also handled regulatory discussions and evidence strategy.

Before that, from 2012 to 2018, Lilian held various roles at Medtronic. Lilian was the DAPT Program Clinical Manager, leading a high-profile coronary stent and antiplatelet medication trial. Lilian managed a global cross-functional team and ensured successful enrollment of subjects. Lilian also served as the Principal Clinical Research Specialist and Senior Clinical Research Specialist during this period.

Lilian started their career as a Research Intern at Roche Pharmaceuticals in 2003. Lilian then pursued their education, completing their Ph.D. in Pharmaceutical Sciences at the University of Southern California in 2010. Lilian also worked as a Graduate Student in Pharmaceutical Sciences at USC during this time.

Overall, Lilian Lee, Ph.D. has extensive experience in clinical research, trial management, and evidence strategy, making their a valuable asset in the field.

Lilian Lee, Ph.D. earned their Bachelor of Arts degree in Cell/Cellular and Molecular Biology with an emphasis in Immunology and a business minor from the University of California, Berkeley in 2004. Lilian then pursued their Ph.D. in Pharmaceutical Sciences at the University of Southern California, completing their degree in 2010. In 2013, they attended UCSC Extension to obtain a certificate in Clinical Trials Essentials.

Links

Previous companies

University of Southern California logo
Medtronic logo

Timeline

  • Senior Director Of Clinical Science

    January 1, 2024 - present

  • Director Of Clinical Science

    August, 2021